13 pending office actions
| App # | Title | Examiner | Art Unit | Status | Filed |
|---|---|---|---|---|---|
| 18537754 | SELECTION BY ESSENTIAL-GENE KNOCK-IN | HILL, KEVIN KAI | 1638 | Non-Final OA | Dec 12, 2023 |
| 18161806 | COMPOSITIONS AND METHODS FOR TREATING CEP290 ASSOCIATED DISEASE | KELLY, ROBERT M | 1638 | Non-Final OA | Jan 30, 2023 |
| 18059213 | SYSTEMS AND METHODS FOR TREATING ALPHA 1-ANTITRYPSIN (A1AT) DEFICIENCY | CHONG, KIMBERLY | 1636 | Non-Final OA | Nov 28, 2022 |
| 17786753 | ENGINEERED CELLS FOR THERAPY | GONZALES, JOSEPHINE MARIA | 1631 | Non-Final OA | Jun 17, 2022 |
| 17836165 | OPTIMIZED CRISPR/CAS9 SYSTEMS AND METHODS FOR GENE EDITING IN STEM CELLS | MONTANARI, DAVID A | 1632 | Final Rejection | Jun 09, 2022 |
| 17757069 | MODIFIED CELLS AND METHODS FOR THE TREATMENT OF HEMOGLOBINOPATHIES | SPENCE, JENNIFER SUZANNE | 1633 | Final Rejection | Jun 08, 2022 |
| 17666390 | CRISPR/CAS-RELATED METHODS AND COMPOSITIONS FOR TREATING SICKLE CELL DISEASE | DHAR, MATASHA | 1632 | Non-Final OA | Feb 07, 2022 |
| 17572403 | CRISPR/CAS-RELATED METHODS, COMPOSITIONS AND COMPONENTS | SINGH, ANOOP KUMAR | 1632 | Final Rejection | Jan 10, 2022 |
| 17533007 | EVALUATION OF CAS9 MOLECULE/GUIDE RNA MOLECULE COMPLEXES | LEITH, NANCY J | 1636 | Final Rejection | Nov 22, 2021 |
| 17433975 | CRISPR/RNA-GUIDED NUCLEASE-RELATED METHODS AND COMPOSITIONS FOR TREATING RHO-ASSOCIATED AUTOSOMAL-DOMINANT RETINITIS PIGMENTOSA (ADRP) | SULLIVAN, STEPHANIE LAUREN | 1635 | Non-Final OA | Aug 25, 2021 |
| 17430382 | MODIFIED NATURAL KILLER (NK) CELLS FOR IMMUNOTHERAPY | GRABER, JAMES J | 1631 | Non-Final OA | Aug 12, 2021 |
| 16474198 | SYNTHETIC GUIDE MOLECULES, COMPOSITIONS AND METHODS RELATING THERETO | VYAS, KEYUR ANILKUMAR | 1637 | Final Rejection | Jun 27, 2019 |
| 16098464 | CRISPR/CAS-RELATED METHODS AND COMPOSITIONS FOR TREATING DUCHENNE MUSCULAR DYSTROPHY | TINSLEY, BRENDAN THOMAS | 1634 | Final Rejection | Nov 02, 2018 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial